Transcatheter Pulmonary Valve (TPV) Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Transcatheter Pulmonary Valve (TPV) Therapy Market: By Product Type (Valves, Delivery System), By End Users (Hospitals, Cardiology Clinics, Ambulatory Surgical Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Transcatheter Pulmonary Valve (TPV) Therapy Market is expected to grow at a CAGR of xx% during the forecast period 2022 to 2028. Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. The Transcatheter Pulmonary Valve (TPV) is a synthetic heart valve created from a cow’s jugular vein valve sewed onto a tiny metal frame. Transcatheter pulmonary valves are delivered through a catheter, which is a thin, hollow, and lengthy tube that is inserted into the heart without the need for open heart surgery while the heart is beating. The transcatheter pulmonary valve is first compressed onto a balloon at the tip of the delivery catheter to deliver into the body, then the balloon in the pulmonary heart valve is inflated to open up the transcatheter pulmonary valve and the catheter is removed from the body, after which it becomes the new pulmonary heart valve. Patients with heart abnormalities who have a failing conduit may benefit from a transcatheter pulmonary valve. The transcatheter pulmonary valve allows patients to postpone the need for additional open heart surgery. Transcatheter Pulmonary Valve (TPV) Therapy Market is being pushed by an increase in the prevalence of comorbidities such as diabetes and cardiovascular illnesses, as well as an increase in the incidence of Congestive Heart Diseases (CHD) among patients of various ages. Transcatheter pulmonary valves are used to extend the functional life of RV-PA conduits, restore pulmonary valve competence, and relieve conduit stenosis in patients without causing regurgitation, making the transcatheter pulmonary valve market profitable over the projected period.

Transcatheter Pulmonary Valve (TPV) Therapy Market

MARKET SUMMARY
-
x% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– x%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Transcatheter Pulmonary Valve (TPV) Therapy Market

  • The report on global Transcatheter Pulmonary Valve (TPV) Therapy Market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, end user and geography.
  • Transcatheter Pulmonary Valve (TPV) Therapy Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Venus MedTech (China)
  • Inova (U.S.)
  • Edward Lifesciences (U.S.)
  • Medtronic Plc. (Ireland)
Dynamics

Transcatheter Pulmonary Valve (TPV) Therapy Market

Increase in the prevalence of congenital heart diseases is a key factor drive the growth of global transcatheter pulmonary valve therapy market. Moreover, prolonged effectiveness of transcatheter valves, increase in the R&D for the innovation of newer products, and change in lifestyle leads to increase in prevalence of cardiovascular diseases are anticipated to fuel the transcatheter pulmonary valve (TPV) therapy market over the forecast period. However, stringent regulatory guidelines, low target population, high cost of therapy, and lack of skilled professionals may restrain the growth of transcatheter pulmonary valve (TPV) therapy market.


North-America got significant share

Transcatheter Pulmonary Valve (TPV) Therapy Market

Geographically, global transcatheter pulmonary valve (TPV) therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America transcatheter pulmonary valve therapy market growth driven by rise in the prevalence of cardiovascular diseases, rise in R&D for the innovation of newer products, and increase in healthcare expenditure. Europe transcatheter pulmonary valve therapy market has a lucrative growth owing high adoption of newer devices, sophisticated healthcare infrastructure, and increase in the prevalence of cardiovascular diseases due to change in lifestyle are boost the market. Asia Pacific transcatheter pulmonary valve therapy market has a significant share, which is attributed to large patient population, development in R&D for the innovation of newer products, and development on healthcare infrastructure are propel the market. Latin America transcatheter pulmonary valve therapy market expected to present notable growth due to expansion of business by the companies and development in economic growth are fuel the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies and regulatory framework
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Transcatheter Pulmonary Valve (TPV) Therapy Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Venus MedTech (China)
  • Inova (U.S.)
  • Edward Lifesciences (U.S.)
  • Medtronic Plc. (Ireland)

Description

Transcatheter Pulmonary Valve (TPV) Therapy Market is expected to grow at a CAGR of xx% during the forecast period 2022 to 2028. Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. The Transcatheter Pulmonary Valve (TPV) is a synthetic heart valve created from a cow’s jugular vein valve sewed onto a tiny metal frame. Transcatheter pulmonary valves are delivered through a catheter, which is a thin, hollow, and lengthy tube that is inserted into the heart without the need for open heart surgery while the heart is beating. The transcatheter pulmonary valve is first compressed onto a balloon at the tip of the delivery catheter to deliver into the body, then the balloon in the pulmonary heart valve is inflated to open up the transcatheter pulmonary valve and the catheter is removed from the body, after which it becomes the new pulmonary heart valve. Patients with heart abnormalities who have a failing conduit may benefit from a transcatheter pulmonary valve. The transcatheter pulmonary valve allows patients to postpone the need for additional open heart surgery. Transcatheter Pulmonary Valve (TPV) Therapy Market is being pushed by an increase in the prevalence of comorbidities such as diabetes and cardiovascular illnesses, as well as an increase in the incidence of Congestive Heart Diseases (CHD) among patients of various ages. Transcatheter pulmonary valves are used to extend the functional life of RV-PA conduits, restore pulmonary valve competence, and relieve conduit stenosis in patients without causing regurgitation, making the transcatheter pulmonary valve market profitable over the projected period.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX